Amy L. Howes

Statistics

Publications

Citations

891

H-Index

Active since

2001

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

University of California San Diego

Arena Pharmaceuticals (United States)

University of Cincinnati

Amy L. Howes is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in life sciences, cell signaling, and signal transduction.

Publications per year

2001–2021

Publications

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells

Ichiro Nakano, Michael Masterman‐Smith, Kuniyasu Saigusa et al. · Journal of Neuroscience Research · 2007 · 159 citations

Medicine, Cancer Biology, Oncology +17

Increased Expression and Activity of RhoA Are Associated With Increased DNA Synthesis and Reduced p27 <sup>Kip1</sup> Expression in the Vasculature of Hypertensive Rats

Tammy M. Seasholtz, Tong Zhang, Michael R. Morissette et al. · Circulation Research · 2001 · 137 citations · Full text

Life Sciences, Biochemistry, Physiology +10

The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures

Amy L. Howes, Gary G. Chiang, Elizabeth S. Lang et al. · Molecular Cancer Therapeutics · 2007 · 134 citations

Medicine, Cancer Biology, Pharmacology +13

3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems

Amy L. Howes, Robyn D. Richardson, Darren Finlay et al. · PLoS ONE · 2014 · 120 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor Activity of Rapamycin in a Transgenic Mouse Model of ErbB2-Dependent Human Breast Cancer

Mei Liu, Amy L. Howes, Jacqueline Lesperance et al. · Cancer Research · 2005 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 11